Which has the lower trailing P/E, INCY or LH?

INCY has the lower trailing P/E: INCY trades at 15.96 and LH at 26.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, INCY or LH?

Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus LH at -2.62%.

Does INCY or LH pay a bigger dividend?

LH pays a dividend (0.92% yield), while INCY has no payments in the available dividend history.

Is INCY or LH more profitable?

INCY runs the higher net margin — INCY at 27.71% versus LH at 6.99%.

How have INCY and LH total returns compared?

Over the past 10 years, INCY delivered 4.38% and LH delivered 10.97% annualized total return. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs Labcorp Holdings Inc. (LH)

A side-by-side comparison of Incyte Corporation and Labcorp Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

INCY

Incyte Corporation

$25.40B

$125.31HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

Labcorp Holdings Inc.

$26.30B

$320.71HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

Total return — INCY vs LH

growth of $100 · dividends reinvested · last 10y

INCY +47.9% (+4.0%/yr)LH +182.6% (+10.9%/yr)LH compounded faster over this window

INCY LH

INCY vs LH: by the numbers

•LH is the larger company ($26.30B vs $25.40B market cap).
•INCY trades at the lower trailing earnings multiple (15.96 vs 26.53 P/E), one valuation lens rather than an overall verdict.
•INCY converts more revenue to profit (27.71% vs 6.99% net margin).
•INCY grew revenue faster over the past five years (16.43% vs -2.62% CAGR).
•LH pays a dividend (0.92% yield), while INCY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	INCY	LH
P/E ratio	15.96	26.53
Forward P/E	33.31	17.48
P/S ratio	4.36	1.83
P/B ratio	4.00	3.06
EV / EBITDA	11.08	14.23
FCF yield	7.56%	4.39%

Profitability

Metric	INCY	LH
Gross margin	92.62%	27.85%
Operating margin	31.57%	11.27%
Net margin	27.71%	6.99%
ROE	25.41%	11.65%
ROIC	22.95%	8.02%

Dividends

Metric	INCY	LH
Dividend yield	N/A	0.92%
Payout ratio	N/A	23.82%

Growth (annualized)

Metric	INCY	LH
Revenue CAGR (5Y)	16.43%	-2.62%
EPS CAGR (5Y)	21.19%	-8.00%
FCF CAGR (5Y)	33.69%	-16.45%
Total return CAGR (5Y)	11.30%	4.91%

Frequently asked

Which has the lower trailing P/E, INCY or LH?: INCY has the lower trailing P/E: INCY trades at 15.96 and LH at 26.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, INCY or LH?: Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus LH at -2.62%.
Does INCY or LH pay a bigger dividend?: LH pays a dividend (0.92% yield), while INCY has no payments in the available dividend history.
Is INCY or LH more profitable?: INCY runs the higher net margin — INCY at 27.71% versus LH at 6.99%.
How have INCY and LH total returns compared?: Over the past 10 years, INCY delivered 4.38% and LH delivered 10.97% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full LH analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio Labcorp P/E ratio Labcorp dividend yield Incyte ROE Labcorp ROE Incyte operating margin Labcorp operating margin Incyte revenue growth Labcorp revenue growth Incyte free cash flow Labcorp free cash flow

Incyte & Labcorp appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.